Mutations in the genes of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) play an essential role in the development of a number of tumors (gliomas, chondroid tumors, leukemia), and are important for the diagnosis and choice of therapy [1,2,3]. The gene discussed is IDH1; the disease is central nervous system cancer.